200 related articles for article (PubMed ID: 25304155)
1. α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes.
Wang S; Chen X; Wei A; Yu X; Niang B; Zhang J
Tumour Biol; 2015 Feb; 36(2):885-92. PubMed ID: 25304155
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 up-regulates ST6Gal-I to promote the adhesive capability of mouse hepatocarcinoma cells to fibronectin via FAK-mediated adhesion signaling.
Yu S; Zhang L; Li N; Fan J; Liu L; Zhang J; Wang S
Biochem Biophys Res Commun; 2012 Oct; 427(3):506-12. PubMed ID: 23022190
[TBL] [Abstract][Full Text] [Related]
3. Sialylated β1, 6 branched N-glycans modulate the adhesion, invasion and metastasis of hepatocarcinoma cells.
Yu X; Zhao Y; Wang L; Chen X; Su Z; Zhang H; Yuan Q; Wang S
Biomed Pharmacother; 2016 Dec; 84():1654-1661. PubMed ID: 27847205
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 up-regulates integrin α2,6-sialylation to promote integrin α5β1-dependent hepatocarcinoma cell adhesion.
Yu S; Fan J; Liu L; Zhang L; Wang S; Zhang J
FEBS Lett; 2013 Mar; 587(6):782-7. PubMed ID: 23416306
[TBL] [Abstract][Full Text] [Related]
5. α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Wang L; Li S; Yu X; Han Y; Wu Y; Wang S; Chen X; Zhang J; Wang S
J Physiol Biochem; 2019 Jun; 75(2):199-207. PubMed ID: 30972697
[TBL] [Abstract][Full Text] [Related]
6. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.
Hedlund M; Ng E; Varki A; Varki NM
Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells.
Chen X; Wang L; Yu X; Wang S; Zhang J
Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397
[TBL] [Abstract][Full Text] [Related]
8. Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto H; Oviedo A; Sweeley C; Saito T; Moskal JR
Cancer Res; 2001 Sep; 61(18):6822-9. PubMed ID: 11559557
[TBL] [Abstract][Full Text] [Related]
9. α2,6 sialylation associated with increased beta 1,6-branched N-oligosaccharides influences cellular adhesion and invasion.
Ranjan A; Kalraiya RD
J Biosci; 2013 Dec; 38(5):867-76. PubMed ID: 24296889
[TBL] [Abstract][Full Text] [Related]
10. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
11. ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.
Chen X; Wang L; Zhao Y; Yuan S; Wu Q; Zhu X; Niang B; Wang S; Zhang J
Oncotarget; 2016 Aug; 7(32):51955-51964. PubMed ID: 27340870
[TBL] [Abstract][Full Text] [Related]
12. Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes.
Zhang Z; Sun J; Hao L; Liu C; Ma H; Jia L
PLoS One; 2013; 8(6):e65218. PubMed ID: 23840320
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.
Shaikh FM; Seales EC; Clem WC; Hennessy KM; Zhuo Y; Bellis SL
Exp Cell Res; 2008 Oct; 314(16):2941-50. PubMed ID: 18703050
[TBL] [Abstract][Full Text] [Related]
14. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
Dall'Olio F; Chiricolo M; D'Errico A; Gruppioni E; Altimari A; Fiorentino M; Grigioni WF
Glycobiology; 2004 Jan; 14(1):39-49. PubMed ID: 14514712
[TBL] [Abstract][Full Text] [Related]
15. [Down-regulation of Ech1 decreases the adhesion ability of mouse hepatocarcinoma Hca-F cells].
Zhang J; Tang JW; Sun MZ; Liu SQ; Song MY; Wang B; Song B; Huang YH
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):605-10. PubMed ID: 23207155
[TBL] [Abstract][Full Text] [Related]
16. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
Seales EC; Jurado GA; Brunson BA; Wakefield JK; Frost AR; Bellis SL
Cancer Res; 2005 Jun; 65(11):4645-52. PubMed ID: 15930282
[TBL] [Abstract][Full Text] [Related]
17. Forced expression of α2,3-sialyltransferase IV rescues impaired heart development in α2,6-sialyltransferase I-deficient medaka.
Omoto T; Wu D; Maruyama E; Tajima K; Hane M; Sato C; Kitajima K
Biochem Biophys Res Commun; 2023 Mar; 649():62-70. PubMed ID: 36745971
[TBL] [Abstract][Full Text] [Related]
18. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.
Amano M; Galvan M; He J; Baum LG
J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376
[TBL] [Abstract][Full Text] [Related]
19. alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells.
Qian J; Zhu CH; Tang S; Shen AJ; Ai J; Li J; Geng MY; Ding J
Acta Pharmacol Sin; 2009 Jul; 30(7):1039-45. PubMed ID: 19483716
[TBL] [Abstract][Full Text] [Related]
20. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
